Randomized phase II trial of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed stage III or IV ovarian cancer

被引：0
|
作者：
Abaid, Lisa [1 ]
Friedman, Richard [2 ]
Brown, John [1 ]
Mendivil, Alberto [1 ]
Beck, Tiffany [1 ]
Corr, Bradley [3 ]
Randall, Leslie [4 ]
Mason, James [5 ]
Hsieh, Candace [6 ]
Nistor, Gabriel [6 ]
Dillman, Robert [6 ]
机构：
[1] Hoag Hosp, Newport Beach, CA USA
[2] Disney Family Canc Ctr, Burbank, CA USA
[3] Univ Colorado, Aurora, CO USA
[4] Univ Calif Irvine, Orange, CA 92668 USA
[5] Scripps Green & Mem Hosp, La Jolla, CA USA
[6] AiVita Biomed Inc, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P391
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
    Turkeri, Levent
    Onol, Fikret Fatih
    Ozyurek, Mustafa
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (03) : 290 - 295
  • [22] Phase I/II study of vaccination with electrofused allogeneic dendritic Cells/Autologous tumor-derived cells in patients with stage IV renal cell carcinoma
    Avigan, David E.
    Vasir, Baldev
    George, Daniel J.
    Oh, William K.
    Atkins, Michael B.
    McDermott, David F.
    Kantoff, Philip W.
    Figlin, Robert A.
    Vasconcelles, Michael J.
    Xu, Yuanxin
    Kufe, Donald
    Bukowski, Ronald M.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (07) : 749 - 761
  • [23] Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients
    Peace, Kaitlin M.
    Vreeland, Timothy J.
    Clifton, Guy T.
    Hale, Diane F.
    Jackson, Doreen O.
    Berry, John S.
    Trappey, Alfred F.
    Herbert, Garth S.
    Hardin, Mark O.
    Nichol, Pauline T.
    Yin, Sook L.
    Yu, Xianzhong
    Wagner, Thomas E.
    Peoples, George E.
    CANCER RESEARCH, 2017, 77
  • [24] Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
    Trepiakas, Redas
    Berntsen, Annika
    Hadrup, Sine Reker
    Bjorn, Jon
    Geertsen, Poul F.
    Straten, Per Thor
    Andersen, Mads H.
    Pedersen, Anders E.
    Soleimani, Amir
    Lorentzen, Torben
    Johansen, Julia S.
    Svane, Inge Marie
    CYTOTHERAPY, 2010, 12 (06) : 721 - 734
  • [25] Autologous dendritic cells loaded with allogeneic tumor cell lysate in patients with mesothelioma: A phase I study
    Aerts, Joachim G.
    Cornelissen, Robin
    van der Leest, Cor
    Eskens, Ferry
    Bezemer, Koen
    Kaijen, Margaretha
    Hendriks, Rudi
    Hegmans, Joost
    Hoogsteden, Henk C.
    CANCER RESEARCH, 2015, 75
  • [26] Effect of Mature Dendritic Cells Primed with Autologous Tumor Antigens from Patients with Epithelial Ovarian Cancer on Stimulation of the Cytotoxic Immune Response in Culture of Mononuclear Cells
    I. A. Obleukhova
    V. V. Kurilin
    M. A. Goncharov
    A. V. Tarkhov
    S. E. Krasil’nikov
    S. V. Sennikov
    Bulletin of Experimental Biology and Medicine, 2013, 156 : 161 - 164
  • [27] Effect of Mature Dendritic Cells Primed with Autologous Tumor Antigens from Patients with Epithelial Ovarian Cancer on Stimulation of the Cytotoxic Immune Response in Culture of Mononuclear Cells
    Obleukhova, I. A.
    Kurilin, V. V.
    Goncharov, M. A.
    Tarkhov, A. V.
    Krasil'nikov, S. E.
    Sennikov, S. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 156 (01) : 161 - 164
  • [28] Phase I trial of Vigil® personalized engineered autologous tumor cells (EATC) in ovarian cancer
    Rocconi, R. P.
    Scalici, J. M.
    Barve, M.
    Manning, L.
    Wallraven, G.
    Senzer, N.
    Nemunaitis, J.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 40 - 41
  • [29] A phase I/II study of vaccination with autologous dendritic cells (DCs) transfected with autologous amplified tumor-derived mRNA in patients with stage IV renal cell carcinoma (RCC).
    Knox, JJ
    Ornstein, D
    Rathmell, KW
    Wong, MKK
    Jewett, M
    Corcos, J
    Finke, LH
    Miesowicz, F
    Nicolette, CA
    Batist, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 430S - 430S
  • [30] AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL
    Liau, Linda M.
    Ashkan, Keyoumars
    Brem, Steven
    Campian, Jian
    Trusheim, John
    Iwamoto, Fabio
    Tran, David
    Anstass, George
    Cobbs, Charles
    Heth, Jason
    Salacz, Michael
    D'Andre, Stacy
    Aiken, Robert
    Moshel, Yaron
    Nam, JooYeon
    Pillainayagam, Clement
    Wagner, Stephanie
    Walter, Kevin
    Chaudary, Rekha
    Goldlust, Samuel
    Lee, Ian
    Bota, Daniela
    Elinzano, Heinrich
    Grewal, Jai
    Lillehei, Kevin
    Mikkelsen, Tom
    Walbert, Tobias
    Abram, Steve
    Brenner, Andrew
    Ewend, Matthew
    Khagi, Simon
    Lovick, Darren
    Portnow, Jana
    Kim, Lyndon
    Loudon, William
    Martinez, Nina
    Thompson, Reid
    Avigan, David
    Fink, Karen
    Geoffroy, Francois
    Giglio, Pierre
    Gligich, Oleg
    Krex, Dietmar
    Lindhorst, Scott M.
    Lutzky, Jose
    Meisel, Hans-Joerg
    Nadji-Ohl, Minou
    Sanchin, Lhagva
    Sloan, Andrew
    Bosch, Marnix
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
12345